drugset / Trial / NCT04130464
Intraperitoneal Infusion of Analgesic for Postoperative Pain Management
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The study is a prospective, double-blinded, placebo-controlled multi-center trial to measure if postoperative pain and the amount of narcotics used are reduced by a clinically significant amount in women undergoing minimally invasive hysterectomy receiving a continuous infusion of intraperitoneal (IP) local anesthetic (LA) or a continuous infusion of LA combined with an NSAID compared with a control group who receives only 0.9% normal saline.
Timeline
- Start
- 2019-09-30
- Primary completion
- 2026-09
- Completion
- 2026-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ketorolac | Other / unclassified | 30 mg | Other |
| Subject | Ropivacaine | Other / unclassified | 0.2 % | Other |
Indications
No indication recorded.